Red X iconGreen tick iconYellow tick icon

Michael Burt

BMedSc MB ChB(Otago) PhD(Q'ld) FRACP


Department of Gastroenterology
Christchurch Hospital
Private Bag 4710
New Zealand

Current Roles

  • Senior Lecturer in Medicine
  • Consultant Gastroenterologist, Christchurch Hospital

Research Interests

  • Liver disease
  • Inflammatory bowel disease

Top 10 Publications

  • Burt MJ, Smit DJ, Pyper WR, Powell LW, Jazwinska EC. A 4.5 megabase YAC contig and physical map over the hemochromatosis gene region. Genomics 1996; 33: 153-8.
  • Burt MJ, George PM, Upton JD, Collett JA, Frampton CMA, Chapman TM, Walmsley TA, Chapman BA. The significance of haemochromatosis gene mutations in the general population: implications for screening. Gut 1998; 43: 830-6.
  • Chapman BA, Burt MJ, Chisholm RJ, Allan RB, Yeo KHJ, Ross AG. Dissolution of gallstones with simvastatin, an HMG CoA reductase inhibitor. Dig Dis Sci 1998; 43: 349-53.
  • Thomas PD, Turner JG, Dobbs BR, Burt MJ, Chapman BA. Use of 99mTc-DISIDA biliary scanning with morphine provocation for the detection of elevated sphincter of Oddi basal pressure. Gut 2000; 46: 838-41
  • Cook HB, Burt MJ, Collett JA, Whitehead MR, Frampton CMA, Chapman BA. Adult coeliac disease: Prevalence and significance. J Gastroenterol Hepatol 2000; 15: 1032-1036.
  • Chapman BA, Burt MJ, Frampton CMA, Chapman TM, Whitehead MR, Upton JD, George PM. Influence of haemochromatosis gene mutations on treatment outcomes in patients with hepatitis C. Int Med J 2001; 31:254-5
  • Burt MJ, Frizelle FA, Barbezat GO. Pregnancy and Exposure to Infliximab (anti-tumor necrosis factor-alpha monoclonal antibody). J Gastroenterol Hepatol 2003; 18: 465-6.
  • Thiopurine S-methyltransferase (TPMT) genotype does not predict adverse drug reactions to thiopurine drugs in patients with inflammatory bowel disease. Gearry RB, Barclay ML, Burt MJ, Collett JA, Chapman BA, Roberts RL, Kennedy MA Aliment Pharmacol Ther 2003; 18: 395-400.
  • A thirty-year (1970-1999) study of coeliac disease in the Canterbury region of New Zealand. Cook HB, Oxner RB, Chapman BA, Frampton CMA, Burt MJ. NZ Med J 2004;
  • Surveillance for dysplasia in patients with inflammatory bowel disease: A national survey of colonoscopic practice in New Zealand. Gearry RB, Wakeman CJ, Barclay ML, Chapman BA, Collett JA, Burt MJ, Frizelle FA. Dis Colon Rectum 2004; 47: 314-22


Mules, T., Stedman, C. A., Ding, S., Burt, M., Gearry, R., Chalmers-Watson, T., Falvey, J., Chapman, B., Barclay, M. L., Lim, G., … Ngu, J. H. (2020). The ABC score accurately predicts mortality in hospitalized patients that develop upper gastrointestinal bleeding. Gastrointestinal Endoscopy, 91(6, Suppl.), (pp. AB590-AB591). doi: 10.1016/j.gie.2020.03.3668

Lamba, M., Daker, C., Metcalf, S., Burt, M., Stedman, C., Chapman, B., & Ngu, J. (2018). Are patients with chronic hepatitis B receiving recommended HCC surveillance? Proceedings of the New Zealand Society of Gastroenterology and the NZNO Gastroenterology Nurses' College Annual Scientific Meeting. Retrieved from

Lamba, M., Burt, M., Alamri, Y., Falvey, J., & Gearry, R. (2017). Predictors of non-attendance at outpatient endoscopy appointments: Five year Canterbury study. Proceedings of the New Zealand Society of Gastroenterology and the NZNO Gastroenterology Nurses' College Annual Scientific Meeting. 37. Retrieved from

Sanders, A. D., Stevenson, C., Pearson, J., Burt, M., McGeoch, G., Hudson, B., & Eglinton, T. W. (2013). A novel pathway for investigation of colorectal symptoms with colonoscopy or computed tomography colonography. New Zealand Medical Journal, 126(1382). Retrieved from

Gardiner, S. J., Gearry, R. B., Burt, M. J., Chalmers-Watson, T., Chapman, B. A., Ross, A. G., Stedman, C. A. M., … Barclay, M. L. (2011). Allopurinol might improve response to azathioprine and 6-mercaptopurine by correcting an unfavorable metabolite ratio. Journal of Gastroenterology & Hepatology, 26(1), 49-54. doi: 10.1111/j.1440-1746.2010.06489.x

Back to top